Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Reeve, Wade Thompson, B. Farrell (2017)
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.European journal of internal medicine, 38
J. Kutner, P. Blatchford, Don Taylor, Christine Ritchie, Janet Bull, Diane Fairclough, Laura Hanson, Thomas LeBlanc, Greg Samsa, S. Wolf, Noreen Aziz, D. Currow, B. Ferrell, N. Wagner-Johnston, S. Zafar, James Cleary, Sandesh Dev, Patricia Goode, Arif Kamal, C. Kassner, Elizabeth Kvale, Janelle McCallum, Adeboye Ogunseitan, S. Pantilat, Russell Portenoy, Maryjo Prince-Paul, Jeff Sloan, K. Swetz, C. Gunten, A. Abernethy (2015)
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: a randomized clinical trial.JAMA internal medicine, 175 5
J. Wastesson, L. Morin, E. Tan, K. Johnell (2018)
An update on the clinical consequences of polypharmacy in older adults: a narrative reviewExpert Opinion on Drug Safety, 17
C. Tannenbaum, Philippe Martin, R. Tamblyn, A. Benedetti, Sara Ahmed (2014)
Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.JAMA internal medicine, 174 6
CM Boyd, J Darer, C Boult, LP Fried, L Boult, AW Wu (2005)
Clinical practice guidelines and quality of Care for Older Patients with Multiple Comorbid Diseases, 294
E. McDonald, Peter Wu, Babak Rashidi, M. Wilson, É. Bortolussi-Courval, Anika Atique, Kiran Battu, A. Bonnici, Sarah Elsayed, A. Wilson, Louise Papillon-Ferland, L. Pilote, Sandra Porter, J. Murphy, S. Ross, Jennifer Shiu, R. Tamblyn, Rachel Whitty, J. Xu, Gabriel Fabreau, Taleen Haddad, A. Palepu, N. Khan, F. McAlister, J. Downar, Allen Huang, T. MacMillan, R. Cavalcanti, T. Lee (2022)
The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older AdultsJAMA Internal Medicine, 182
E. Bayliss, S. Shetterly, M. Drace, J. Norton, M. Maiyani, Kathy Gleason, Jennifer Sawyer, L. Weffald, A. Green, E. Reeve, M. Maciejewski, O. Sheehan, J. Wolff, C. Kraus, C. Boyd (2022)
Deprescribing Education vs Usual Care for Patients With Cognitive Impairment and Primary Care CliniciansJAMA Internal Medicine, 182
AJ Doherty, P Boland, J Reed (2020)
Barriers and facilitators to deprescribing in primary care: a systematic review, 4
M. Steinman, C. Boyd, M. Spar, J. Norton, C. Tannenbaum (2021)
Deprescribing and deimplementation: Time for transformative changeJournal of the American Geriatrics Society, 69
K. Weir, Nagham Ailabouni, C. Schneider, S. Hilmer, E. Reeve (2021)
Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-AnalysisThe Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 77
C. Boyd, J. Darer, C. Boult, L. Fried, L. Boult, A. Wu (2005)
Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance.JAMA, 294 6
A. Pottegård, L. Morin, J. Hallas, T. Gerhard, A. Winterstein, S. Perez-Gutthann, Mina Tadrous (2021)
Where to begin? Thirty must‐read papers for newcomers to pharmacoepidemiologyPharmacoepidemiology and Drug Safety, 31
JP Sheppard, J Burt, M Lown (2020)
Effect of antihypertensive medication reduction vs usual care on short‐term blood pressure control in patients with hypertension aged 80 years and older, 323
I. Scott, J. Soon, A. Elshaug, Robyn Lindner (2017)
Countering cognitive biases in minimising low value careMedical Journal of Australia, 206
J. Sheppard, J. Burt, M. Lown, Eleanor Temple, Rebecca Lowe, Rosalyn Fraser, Julie Allen, G. Ford, C. Heneghan, F. Hobbs, S. Jowett, Shahela Kodabuckus, P. Little, J. Mant, J. Mollison, R. Payne, Marney Williams, Ly-Mee Yu, R. McManus (2020)
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.JAMA, 323 20
I. Scott, S. Hilmer, E. Reeve, K. Potter, D. Couteur, Deborah Rigby, D. Gnjidic, C. Mar, E. Roughead, A. Page, J. Jansen, Jennifer Martin (2015)
Reducing inappropriate polypharmacy: the process of deprescribing.JAMA internal medicine, 175 5
J. Isenor, Isaac Bai, Rachel Cormier, M. Helwig, E. Reeve, A. Whelan, S. Burgess, R. Martin-Misener, Natalie Kennie-Kaulbach (2020)
Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: A scoping review.Research in social & administrative pharmacy : RSAP
B. Farrell, K. Pottie, C. Rojas-Fernandez, L. Bjerre, Wade Thompson, V. Welch (2016)
Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for DeprescribingPLoS ONE, 11
D Gnjidic, M Johansson, DM Meng, B Farrell, A Langford, E Reeve (2022)
Achieving sustainable healthcare through deprescribing, 2022
Mouna Sawan, E. Reeve, J. Turner, A. Todd, M. Steinman, M. Petrovic, D. Gnjidic (2020)
A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative reviewExpert Review of Clinical Pharmacology, 13
H. Holmes, D. Hayley, G. Alexander, G. Sachs (2006)
Reconsidering medication appropriateness for patients late in life.Archives of internal medicine, 166 6
INTRODUCTIONDeprescribing is the planned and supervised process of stopping a medication when that medication may no longer be necessary, is causing more harm than good or does not align with a person's healthcare goals and treatment preferences. There has been an explosion of deprescribing research published over the last 10 years. Researchers in the field have been doing everything from evaluating deprescribing rates in usual care to studying barriers and facilitators around establishing deprescribing in routine clinical practice. More recently, interventions specifically designed to intervene on major determinants of deprescribing have been developed and tested. For someone new to the field (e.g., researchers new to the field, trainees or clinicians interested in learning more about deprescribing research), it might be difficult to know where to begin in order to gain a solid grasp of the deprescribing literature.At the 1st International Conference on Deprescribing, held in Denmark in September 2022, this author group discussed which deprescribing articles represented work that collectively provides a diverse overview of the field for newcomers. We hoped such a collection of articles would provide an overview of the breadth of work in this area and highlight seminal pieces that shaped the field. We were inspired by
Basic & Clinical Pharmacology & Toxicology – Wiley
Published: Dec 1, 2023
Keywords: deprescribing; geriatrics; medication appropriateness; older adults; polypharmacy
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.